1. Home
  2. NBTX vs MFM Comparison

NBTX vs MFM Comparison

Compare NBTX & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • MFM
  • Stock Information
  • Founded
  • NBTX 2003
  • MFM 1986
  • Country
  • NBTX France
  • MFM United States
  • Employees
  • NBTX N/A
  • MFM N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • MFM Finance Companies
  • Sector
  • NBTX Health Care
  • MFM Finance
  • Exchange
  • NBTX Nasdaq
  • MFM Nasdaq
  • Market Cap
  • NBTX 201.9M
  • MFM 219.5M
  • IPO Year
  • NBTX 2020
  • MFM N/A
  • Fundamental
  • Price
  • NBTX $3.75
  • MFM $5.51
  • Analyst Decision
  • NBTX Strong Buy
  • MFM
  • Analyst Count
  • NBTX 1
  • MFM 0
  • Target Price
  • NBTX $12.00
  • MFM N/A
  • AVG Volume (30 Days)
  • NBTX 8.9K
  • MFM 108.1K
  • Earning Date
  • NBTX 09-18-2024
  • MFM 01-01-0001
  • Dividend Yield
  • NBTX N/A
  • MFM 4.08%
  • EPS Growth
  • NBTX N/A
  • MFM N/A
  • EPS
  • NBTX N/A
  • MFM 0.03
  • Revenue
  • NBTX $45,220,186.00
  • MFM N/A
  • Revenue This Year
  • NBTX N/A
  • MFM N/A
  • Revenue Next Year
  • NBTX N/A
  • MFM N/A
  • P/E Ratio
  • NBTX N/A
  • MFM $176.67
  • Revenue Growth
  • NBTX 526.17
  • MFM N/A
  • 52 Week Low
  • NBTX $2.76
  • MFM $4.37
  • 52 Week High
  • NBTX $7.51
  • MFM $5.48
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 53.25
  • MFM 56.54
  • Support Level
  • NBTX $3.60
  • MFM $5.43
  • Resistance Level
  • NBTX $3.95
  • MFM $5.53
  • Average True Range (ATR)
  • NBTX 0.19
  • MFM 0.06
  • MACD
  • NBTX -0.01
  • MFM 0.00
  • Stochastic Oscillator
  • NBTX 38.18
  • MFM 83.33

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About MFM MFS Municipal Income Trust

MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.

Share on Social Networks: